Concentric Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.83M | Buy |
54,695
+3,605
| +7% | +$187K | 0.69% | 56 |
|
|
2024
Q2 | $2.12M | Buy |
51,090
+3,133
| +7% | +$130K | 0.55% | 60 |
|
|
2024
Q1 | $2.6M | Buy |
47,957
+4,245
| +10% | +$230K | 0.69% | 57 |
|
|
2023
Q4 | $2.24M | Buy |
43,712
+7,119
| +19% | +$365K | 0.65% | 58 |
|
|
2023
Q3 | $2.12M | Buy |
36,593
+770
| +2% | +$44.7K | 0.7% | 56 |
|
|
2023
Q2 | $2.29M | Buy |
35,823
+1,237
| +4% | +$79.1K | 0.73% | 57 |
|
|
2023
Q1 | $2.4M | Buy |
34,586
+179
| +0.5% | +$12.4K | 0.79% | 53 |
|
|
2022
Q4 | $2.48M | Sell |
34,407
-252
| -0.7% | -$18.1K | 0.85% | 49 |
|
|
2022
Q3 | $2.46M | Buy |
34,659
+85
| +0.2% | +$6.04K | 0.91% | 45 |
|
|
2022
Q2 | $2.66M | Buy |
34,574
+325
| +0.9% | +$25K | 0.9% | 46 |
|
|
2022
Q1 | $2.5M | Buy |
34,249
+680
| +2% | +$49.7K | 0.72% | 55 |
|
|
2021
Q4 | $2.09M | Buy |
33,569
+3,190
| +11% | +$199K | 0.59% | 63 |
|
|
2021
Q3 | $1.8M | Buy |
30,379
+2,258
| +8% | +$134K | 0.55% | 64 |
|
|
2021
Q2 | $1.88M | Buy |
28,121
+924
| +3% | +$61.7K | 0.58% | 64 |
|
|
2021
Q1 | $1.72M | Buy |
27,197
+4,410
| +19% | +$278K | 0.57% | 63 |
|
|
2020
Q4 | $1.41M | Buy |
22,787
+2,690
| +13% | +$167K | 0.52% | 68 |
|
|
2020
Q3 | $1.21M | Buy |
20,097
+25
| +0.1% | +$1.51K | 0.52% | 66 |
|
|
2020
Q2 | $1.18M | Sell |
20,072
-415
| -2% | -$24.4K | 0.55% | 62 |
|
|
2020
Q1 | $1.14M | Buy |
20,487
+1,955
| +11% | +$109K | 0.63% | 59 |
|
|
2019
Q4 | $1.19M | Buy |
18,532
+11,792
| +175% | +$757K | 0.51% | 64 |
|
|
2019
Q3 | $342K | Buy |
6,740
+140
| +2% | +$7.1K | 0.22% | 75 |
|
|
2019
Q2 | $299K | Buy |
6,600
+2,105
| +47% | +$95.4K | 0.19% | 78 |
|
|
2019
Q1 | $214K | Buy |
+4,495
| New | +$214K | 0.14% | 85 |
|